FDG PET evaluates immunotherapy for non-small cell lung cancer
Monday, June 13, 2016 - 22:00
in Health & Medicine
Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers now report a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient's own immune system.